We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
202 hedge funds and large institutions have $2.49B invested in Denali Therapeutics in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 92 increasing their positions, 51 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
80% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 51
18% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 22
2% more funds holding
Funds holding: 199 → 202 (+3)
1.06% more ownership
Funds ownership: 77.97% → 79.04% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
15% less capital invested
Capital invested by funds: $2.93B → $2.49B (-$441M)
91% less call options, than puts
Call options by funds: $999K | Put options by funds: $11.1M
Holders
202
Holders Change
+3
Holders Change %
+1.51%
% of All Funds
3.22%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
26
Increased
92
Reduced
51
Closed
22
Calls
$999K
Puts
$11.1M
Net Calls
-$10.1M
Net Calls Change
-$11.8M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$36.9M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$13.9M |
| 3 |
Temasek Holdings
Singapore
|
+$10.5M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.73M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$8.63M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.8M |
| 2 |
AVM
Arch Venture Management
Chicago,
Illinois
|
-$30.3M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$16.8M |
| 4 |
CM
Crestline Management
Fort Worth,
Texas
|
-$12.4M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7M |
